New program aims to level the playing field for minority cancer patients seeking advanced treatments
NCT ID NCT05375643
Summary
This study tests a support program designed to help Black, Latino, and older adult cancer patients overcome barriers to getting genetic testing. Genetic testing is often required to qualify for newer, targeted cancer treatments and clinical trials. The program includes a patient guide, educational videos, and text messages to help patients understand and access these important tests.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Dana-Farber Cancer Institute at St. Elizabeth's Medical Center
RECRUITINGBrighton, Massachusetts, 02135, United States
Contact Email: •••••@•••••
Contact
-
Dana-Farber Cancer Instiute - Merrimack Valley
NOT_YET_RECRUITINGMethuen, Massachusetts, 01844, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.